Prothena Corp Public PRTA
NASDAQ PRTA
$8.36 -0.18 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Return on Sales [ROS] (2013 - 2026)

Updated

Prothena Corp Public (PRTA) posted Return on Sales [ROS] of -2089.21% for Q2 2026, down 174.82 percentage points from -1914.39% a year earlier and down 2148.00 percentage points from the prior quarter.

Analysis

Prothena Corp Public (PRTA) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Prothena Corp Public was -101.80%, up 2621.41 percentage points year-over-year; for FY2025, it came in at -2216.44%, down 2102.08 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +10999.74 percentage points (FY2020 to FY2025).
  • In prior years, Prothena Corp Public's Return on Sales [ROS] was -114.36% in FY2024 (+94.72 pp), -209.08% in FY2023 (+34.97 pp), -244.05% in FY2022 (-279.94 pp) and 35.88% in FY2021 (+13252.06 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -163056.00% in Q1 2024 to a high of 78.48% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of +8612.14 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2025, with a gain of 160737.01 percentage points; the weakest was Q1 2024, with a drop of 160459.18 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 58.80% (Q1 2026), -115252.38% (Q4 2025) and -1666.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Prothena Corp Public 441.90 Mn -814.18 Mn - -2,089.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,089.21%
Mar 31, 2026 58.80%
Dec 31, 2025 -115,252.38%
Sep 30, 2025 -1,666.25%
Jun 30, 2025 -1,914.39%
Mar 31, 2025 -2,318.99%
Dec 31, 2024 -3,056.85%
Sep 30, 2024 -6,857.01%
Jun 30, 2024 44.22%
Mar 31, 2024 -163,056.00%
Dec 31, 2023 -24,846.52%
Sep 30, 2023 12.15%
Jun 30, 2023 -1,654.74%
Mar 31, 2023 -2,596.82%
Dec 31, 2022 -0.14%
Sep 30, 2022 -3,317.86%
Jun 30, 2022 -3,293.37%
Mar 31, 2022 -3,290.89%
Dec 31, 2021 -2,823.55%
Sep 30, 2021 78.48%
API Access

Prothena Corp Public Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PRTA&period=max&api_key=YOUR_API_KEY